V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007228 | 190001811 | null | null | null | null | 2017-08-09 | Docetaxel 75mg/m2 (21 day) | null | null | CISPLATIN + RT | 101566965 |
| 190007234 | 190001812 | null | null | null | null | 2020-02-19 | Cisplatin 7 day | null | null | CISPLATIN | 100586654 |
| 190007240 | 190001815 | null | null | null | null | 2019-09-12 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 101621871 |
| 190007247 | 190001819 | 1.61 | 22.6 | Palliative (P) | 2016-10-31 | 2016-11-13 | Everolimus 10mg | 01 | N | PACLITAXEL | 101041545 |
| 190007255 | 190001824 | null | null | null | null | 2017-10-04 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 100201990 |
| 190007267 | 190001829 | null | null | Palliative (P) | 2018-08-27 | 2018-09-09 | EW EuroEwing 2012 Arm B IE | null | N | CAPECITABINE | 100050891 |
| 190007270 | 190001830 | 0 | 132 | null | 2019-09-27 | 2019-10-02 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 100147824 |
| 190007276 | 190001834 | null | null | null | null | 2019-01-02 | Abiraterone | null | null | CAPECITABINE + OXALIPLATIN | 101020724 |
| 190007279 | 190001835 | 1.79 | 55.8 | Curative (C) | 2018-03-13 | 2018-03-16 | Oxaliplatin + Modified de Gramont | N | N | EVEROLIMUS | 100632624 |
| 190007294 | 190001838 | 1.8 | 66.9 | Adjuvant (A) | 2015-02-11 | 2015-02-11 | Doxorubicin + Olaratumab | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101777522 |
| 190007298 | 190001840 | null | null | null | null | 2018-12-29 | EW EuroEwing 2012 Arm A VAI | null | null | GEMCITABINE | 100588413 |
| 190007300 | 190001841 | null | null | null | null | 2018-11-01 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | null | CAPECITABINE | 101064776 |
| 190007302 | 190001843 | 1.62 | 65.5 | Curative (C) | 2018-05-13 | 2018-05-25 | EOX | 02 | N | LANREOTIDE | 100186441 |
| 190007305 | 190001845 | null | 111 | Curative (C) | 2017-05-18 | 2017-06-14 | OST Euramos 1 Closed Trial - AP | 02 | Y | OCTREOTIDE | 101313170 |
| 190007306 | 190001846 | 1.66 | 53 | Curative (C) | 2019-10-22 | 2019-10-23 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | CARBOPLATIN + CETUXIMAB + FLUOROURACIL | 100791055 |
| 190007307 | 190001847 | 0 | 104 | Curative (C) | 2016-08-11 | 2016-08-25 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101234427 |
| 190007308 | 190001848 | 1.75 | 67 | Palliative (P) | 2010-03-18 | 2017-02-20 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100164292 |
| 190007321 | 190001853 | 1.64 | 64.3 | 03 | 2019-12-23 | 2019-12-30 | Cisplatin + Docetaxel +Fluorouracil | N | Y | CAPECITABINE + OXALIPLATIN | 101846914 |
| 190007323 | 190001854 | 1.67 | 69.2 | null | null | 2020-02-28 | Cisplatin | null | null | CISPLATIN | 100050738 |
| 190007324 | 190001855 | null | null | null | null | 2018-09-21 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 100323655 |
| 190007325 | 190001856 | null | null | null | null | 2018-02-10 | Cisplatin 100 + RT(H&N) 1 day | null | null | CISPLATIN | 100751351 |
| 190007332 | 190001859 | null | null | null | null | 2019-05-04 | OST Euramos 1 Closed Trial - AP | null | null | CAPECITABINE + STREPTOZOCIN | 100964087 |
| 190007333 | 190001860 | null | null | null | null | 2019-10-31 | ECX | null | null | ECARBOX | 101624218 |
| 190007338 | 190001862 | 1.59 | 83.8 | Palliative (P) | 2017-01-07 | 2017-01-08 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | CISPLATIN + FLUOROURACIL | 100739536 |
| 190007351 | 190001866 | null | null | null | null | 2018-06-11 | EW EuroEwing 2012 Arm A VIDE | null | null | METHOTREXATE + VINBLASTINE | 101365746 |
| 190007352 | 190001867 | null | null | null | null | 2019-05-10 | OCTREOTIDE | null | null | GEMCARBO | 100820241 |
| 190007367 | 190001870 | 1.67 | 51.9 | Palliative (P) | 2016-07-09 | 2016-07-09 | NB Low/Interm risk guidelines Carbo/Etop | 02 | N | CAPECITABINE | 100130976 |
| 190007383 | 190001875 | null | null | null | null | 2016-07-30 | Cisplatin + Radiotherapy + CISPLATIN | null | null | CISPLATIN | 100059284 |
| 190007390 | 190001877 | null | null | null | null | 2019-03-23 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100121193 |
| 190007391 | 190001878 | null | null | null | null | 2017-02-15 | EURAMOS TRIAL | null | null | EOX | 101381997 |
| 190007402 | 190001882 | 1.65 | 86.45 | Curative (C) | 2016-08-03 | 2016-08-09 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | CISPLATIN + RT | 100907940 |
| 190007404 | 190001883 | 1.78 | 23.3 | Palliative (P) | 2018-10-12 | 2018-10-15 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100343829 |
| 190007405 | 190001884 | 1.53 | 61.9 | Neo-adjuvant (N) | 2017-10-29 | 2017-11-03 | Pazopanib | 01 | N | CARBOPLATIN + DOCETAXEL | 100913634 |
| 190007411 | 190001886 | 0 | 101.7 | Curative (C) | 2019-10-18 | 2019-10-25 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | CISPLATIN | 100663253 |
| 190007415 | 190001887 | 1.57 | 22.5 | Neo-adjuvant (N) | 2017-05-05 | 2017-05-09 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101544675 |
| 190007439 | 190001896 | null | null | null | null | 2016-06-17 | Capecitabine | null | null | OCTREOTIDE | 101075713 |
| 190007441 | 190001898 | null | null | null | null | 2018-12-21 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 100399374 |
| 190007446 | 190001900 | 1.52 | 52.5 | null | 2017-10-14 | 2017-10-23 | Cisplatin + Doxorubicin | N | N | CISPLATIN + DOXORUBICIN | 101122694 |
| 190007451 | 190001903 | 1.82 | 105.7 | Curative (C) | 2016-05-14 | 2016-05-14 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CETUXIMAB | 101105962 |
| 190007453 | 190001905 | 1.57 | 100.3 | Palliative (P) | 2016-12-06 | 2016-12-10 | EW EuroEwing 2012 Arm A VIDE | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100432894 |
| 190007457 | 190001907 | 0 | 101.7 | Curative (C) | 2016-05-21 | 2016-05-21 | EURO-EWING | 02 | N | FCIST | 101264600 |
| 190007458 | 190001908 | null | null | null | null | 2016-09-25 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101252597 |
| 190007464 | 190001911 | null | null | null | null | 2017-07-28 | LANREOTIDE | null | null | FLUOROURACIL + OXALIPLATIN | 100312793 |
| 190007466 | 190001912 | null | null | null | null | 2018-11-19 | Cisplatin + Docetaxel +Fluorouracil | null | null | CARBOPLATIN + ETOPOSIDE | 100386674 |
| 190007469 | 190001914 | 1.67 | 70.2 | Curative (C) | 2019-10-30 | 2019-10-31 | Cisplatin 100 + RT(H&N) 1 day | null | Y | CISPLATIN | 101202023 |
| 190007472 | 190001916 | 1.62 | 69.2 | Palliative (P) | 2017-05-05 | 2017-05-05 | Carboplatin + Etoposide IV 3 day | 02 | N | CARBOPLATIN + ETOPOSIDE | 101086787 |
| 190007479 | 190001918 | 1.85 | 92.8 | Curative (C) | 2018-11-25 | 2018-12-06 | LANREOTIDE | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100420499 |
| 190007484 | 190001920 | 1.52 | 80 | Palliative (P) | 2016-08-06 | 2016-08-08 | EURAMOS TRIAL | 02 | N | EOX | 101014638 |
| 190007488 | 190001922 | null | null | null | null | 2016-07-21 | Dox + HD Mtx (post PAM) | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101416184 |
| 190007497 | 190001926 | 1.65 | 101.6 | Adjuvant (A) | 2018-07-29 | 2018-07-29 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | ECX | 101185860 |